High levels of human apolipoprotein A-I and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins. Relevance to regression of atherosclerosis?

Keywords

Cholesterol, Endocrinology, Apolipoprotein B, Internal medicine, Efflux

References

• Cellular cholesterol efflux. Role of cell membrane kinetic pools and interaction with apolipoproteins AI, AII, and Cs.F.H. Mahlberg, George H. Rothblat — 1992
• A comparative study on the removal of cellular lipids from Landschütz ascites cells by human plasma apolipoproteins.Richard L. Jackson, A M Gotto, Oliver Stein — 1975
• High density lipoprotein metabolism.S Eisenberg — 1984
• Molecular physiology of reverse cholesterol transport.C J Fielding, P E Fielding — 1995
• Dexamethasone impairs cholesterol egress from a localized lipoprotein depot in vivo.Oliver Stein, Y. Dabach, G. Hollander — 1998
• The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine.Oliver Stein, Y. Stein, Michael Lefevre — 1986
• Role of apolipoproteins in cellular cholesterol efflux.J G DeLamatre, Gertrud Wolfbauer, Michael C. Phillips — 1986
• Comparison of cholesterol egress from cultured cells enriched with cholesterol ester after exposure to cationized LDL or to LDL and chloroquine.Oliver Stein, G. Halperin, Y. Stein — 1979
• Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein ReceptorSusan Acton, Attilio Rigotti, Katherine T. Landschulz — 1996
• Protection Against Atherogenesis in Mice Mediated by Human Apolipoprotein A-IVNicolas Duverger, Günter Tremp, Jean‐Michel Caillaud — 1996
• Cholesterol efflux in vivo from a depot of cationized LDL injected into a thigh muscle of small rodents.Olga Stein, Y. Dabach, G. Hollander — 1997
• Lipoprotein lipase in heart cell cultures is suppressed by bacterial lipopolysaccharide: an effect mediated by production of tumor necrosis factor.G. Friedman, Ruth Gallily, Tova Chajek‐Shaul — 1988
• Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low density and high density lipoproteins: relevance to the recovery problem during delipidation of serum lipoproteins.A M Scanu, Celina Edelstein — 1971
• High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithinchoesteryl acyltransferaseAnnie M. Bérard, Bernhard Föger, Alan T. Remaley — 1997
• Kinetic parameters for high density lipoprotein apoprotein AI and cholesteryl ester transport in the hamster.L A Woollett, D K Spady — 1997
• Reverse cholesterol transport--a review of the process and its clinical implications.Stephen Hill, Matthew J McQueen — 1997
• Metabolism of HDL-cholesteryl ester in the rat, studied with a nonhydrolyzable analog, cholesteryl linoleyl ether.Y. Stein, Y. Dabach, G. Hollander — 1983
• Effect of macrophage colony stimulating factor on the advanced atherosclerosis in Watanabe heritable hyperlipidemic rabbits.Yuichiro Watanabe, T Inaba, Hitoshi Shimano — 1997
• Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.Graciela Castro, Laurence Parmentier Nihoul, Catherine Dengremont — 1997
• Delayed loss of cholesterol from a localized lipoprotein depot in apolipoprotein A-I-deficient mice.Olga Stein, Y. Dabach, G. Hollander — 1997

Cited by

• High-density lipoprotein heterogeneity and function in reverse cholesterol transportGeorge H. Rothblat, Michael C. Phillips — 2010
• Low High-Density Lipoprotein CholesterolMartin Hersberger, Arnold von Eckardstein — 2012
• Clearance of cationized LDL cholesterol from a muscle depot is not enhanced in human apolipoprotein A-IV transgenic mice.Y. Stein, Oliver Stein, Nicolas Duverger — 2000
• Macrophage Cholesterol Metabolism, Apolipoprotein E, and Scavenger Receptor AI/II mRNA in Atherosclerosis-Susceptible and -Resistant MiceGideon Friedman, Arie Ben‐Yehuda, Y. Dabach — 2000
• Can Atherosclerosis Regress?J Kunz — 2002
• Antiatherogenic role of high-density lipoproteins: insights from genetically engineered-mice.Joan Carles Escolà‐Gil — 2006
• High-density lipoproteins and atherosclerosis.Daniel J. Rader — 2002
• Dynamics of reverse cholesterol transport: protection against atherosclerosis.Dmitri Sviridov, Paul J. Nestel — 2002
• Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans.M. Nazeem Nanjee, C. Justin Cooke, Roy A. Garvin — 2001
• Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo.Y. Zhang — 2005
• Overexpression of Apolipoprotein A-I Promotes Reverse Transport of Cholesterol From Macrophages to Feces In VivoYuzhen Zhang, Ilaria Zanotti, Muredach P. Reilly — 2003
• Atheroprotective mechanisms of HDL.Olga Stein, Yechezkiel Stein — 1999
• Inflammation and skin cholesterol in LDLr−/−, apoA-I−/− mice: link between cholesterol homeostasis and self-tolerance? Published, JLR Papers in Press, October 28, 2006.Manal Zabalawi, Manish S. Bharadwaj, H. V. Horton — 2007
• Novel in vivo Method for Measuring Cholesterol Mass Flux in Peripheral MacrophagesGinny L. Weibel, Sara A. Hayes, Aisha Wilson — 2011
• Effect of atherogenic diet on reverse cholesterol transport in vivo in atherosclerosis susceptible (C57BL/6) and resistant (C3H) mice.Oliver Stein — 2001
• Estudio de las propiedades antiaterogénicas de las HDL de ratones transgénicos de apoA-II humanaVicent Ribas Serra — 2005
• HDL AND REVERSE CHOLESTEROL TRANSPORT IN HUMANS AND ANIMALS: LESSONS FROM PRE-CLINICAL MODELS AND CLINICAL STUDIES.Ilaria Zanotti, Francesco Potì, Marina Cuchel — 2021
• Autres dyslipidémies génétiquesSylvie Picard — 2000
• The Role of the Vascular Extracellular Matrix and the Age-Related Changes of ArteriesJ. Kunz — 2002
• Avaluació del Transport Revers de Colesterol Específic de MacròfagsNoemi Rotllan Vila — 2008

Related papers

• Abstract 502: CSL112, a Novel Formulation of Human ApoA-I, Enhances the Capacity of Serum to Efflux Cholesterol from MacrophagesAndreas Gille, Svetlana Diditchenko, Elizabeth Leary — 2012
• Targeted inhibition of ATP‐binding cassette transporter A1 protein degradation promotes reverse cholesterol transport and reduces atherosclerosis in mice (832.15)Linzhang Huang, Haibo Zhu — 2014
• Relative Contributions of ABCA1 and SR-BI to Cholesterol Efflux to Serum From Fibroblasts and MacrophagesMyNgan Duong, Heidi L. Collins, Weijun Jin — 2005
• Is it time to modify the reverse cholesterol transport model?Alan R. Tall, Nan Wang, Phillip Mucksavage — 2001
• [Role of HDL in Cholesterol Efflux and Reverse Cholesterol Transport].Makoto Ayaori — 2016
• Correlation of apoA-I and ABCAl in Reverse Cholesterol TransportLI Yingqing — 2005
• [Reverse cholesterol transport in cultured gallbladder epithelial cells].Jin Lee, Ho Soon Choi — 2004
• A Pathway-Dependent on ApoE, ApoAI, and ABCA1 Determines Formation of Buoyant High-Density Lipoprotein by Macrophage Foam CellsPatricia G. Yancey, Hong Yu, MacRae F. Linton — 2007
• Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease.H. Bryan Brewer, Alan T. Remaley, Edward B. Neufeld — 2004
• Impact of Hepatic ABCA1 (ATP-Binding Cassette Transporter A1) Deletion on Reverse Cholesterol Transport A New Clue in Solving Complex HDL (High-Density Lipoprotein) Metabolism.Makoto Sasaki, Tomohiro Komatsu, Katsunori Ikewaki — 2019